Summary.-The natural history of 45 cases of smouldering leukaemia has been studied. Males and females were equally represented, with a median age of 60-5. The median survival of the whole group was only 20 months, but rare cases lived 10 years or longer. 38% developed acute leukaemia; the remainder usually died of the results of marrow failure. Although it was possible to divide these marrow dysplasias morphologically into 3 major subgroups (refractory anaemia with excess of myeloblasts, chronic myelomonocytic leukaemia and chronic erythraemic myelosis), several displayed transitional features. Many showed refractory macrocytosis at diagnosis. The survival of the 3 groups was similar, though patients with high monocyte counts tended to present with less anaemia and fared rather better than the others. Statistical analysis suggests that increasing age, severe anaemia, thrombocytopenia and hepatomegaly are associated with a poor prognosis. Chemotherapy, when attempted, was usually unsuccessful.
THE TERM smouldering ("oligoblastic") leukaemia was introduced by Rheingold et al. (1963) to distinguish a group of patients, usually presenting with single or multiple cytopenias, whose marrows, while showing some of the maturation defects of acute myeloblastic or myelomonocytic leukaemia, differ from these in having a lower proportion of marrow blast cells. Clinically, the condition is more indolent than acute leukaemia, and particularly affects older individuals. A number of descriptive morphological terms have been applied to this syndrome, of which refractory anaemia with excess of myeloblasts (RAEM) (Dreyfus et al., 1970) , chronic myelomonocytic leukaemia (CMML) (Miescher & Farquet, 1974; Geary et al., 1975) , chronic erythraemic myelosis (CEM) (Kass & Schnitzer, 1975) and, less commonly, chronic erythromonocytic leukaetnia (Broun, 1969) are among those used.
However, it has been quiestioned whether subdivision into such categories is valid, and whether thev have any clinical relevance.
In this study, 45 cases of smouldering leukaemia investigated in a single clinic have been followed for periods of up to 14 years, in an attempt to identify clinical and/or haematological features of possible prognostic significance. We also attempted to assess the validity of classifying our cases into 3 of the morphological types mentioned above. (Bennett, et al., 1976) . In the blood. the following parameters were assessed: degree of anaemia. neutropenia, monocytosis and thrombocytopenia, and the presence of myeloblasts or nucleated red cells. In addition to the proportion of blast cells, the following morphological features were evaluated in the marrow: degree of monocytosis. number of megakaryocytes and their morphology, and the degree of dyserythropoiesis, with particular reference to the proportion of multinucleated erythroid precursors. and to the type and number of sideroblasts, as described by Mollin (1965) and Hast (1978) . Marrow smears were stained with Prussian blue for the demonstration of non-haem iron in the ervthroblasts. "Ringed" sideroblasts were defined as erythroblasts with large siderotic granules arranged in a perinuclear ring or collar, covering at least one-third of the circumference of the nucleus. "Intermediate" sideroblasts were defined as normoblasts with more than 6 non-haem iron granules, but diffusely scattered in the cytoplasm. Only patients with a predominance of "rings" (i.e. > 5000 of the total number of sideroblasts) w ere included in the ringed sideroblast group. The "intermediate" group consisted of the remaining patients. with mainly intermediate sideroblasts.
On the basis of these morphological features, in blood and marrow, the patients were allocated to one of the 3 main types of oligoblastic leukaemia: RAEM, CMAIL and CEM. fn some cases, marrow cultures for CFU-C. CFU-E and cytogenetic analysis -were undertaken. The prognostic value of these has already been reported (Milner etal., 1977 which were then compared using the logrank test (Peto et al., 1977) . For conuous variables, a convenient number of categories was first of all defined, and a log-rank P value for trend calculated.
(2) The Cox regression method was used to detect prognostic variables. This multivariate analysis has the advantage that the merit of each variable at each stage is assessed. whilst correcting for the effects of any other variables in the analysis. If hazard function A(t) is the chance of dying in month t in the patients alive at the beginning of the month. we assume
where Ao(t) is a standard hazard function and a = zlil + Z2/2 +. + Zppp where the z's are a set of p prognostic variables and the f's are coefficients estimated by a maximum-likelihood iterative procedure. A stepwise procedure wNas adopted. First, the most important single predictor was found, and the next variable to be added to the analysis was the one which most improved the log-likelihood. More variables were added until none of them could significantly improve the loglikelihood.
RESU LTS
The age range of the patients was years, with a median of 60'5. Males and females were almost equally represented. The presenting signs and symptoms are shown in Table I . The most frequently encountered symptoms were those attribu- Table II . There was a wide range in the total white-cell count, but most; were low, with a median of 4 0 x 109/I. Most, of the patients were anaemic, with a median haemoglobin value of 8 8 g/dl. The platelet counts ranged from < 10 x 109/1 to 324 x 109/1, with a median of 61 x 109/1. The peripheral-blood films showed a variety of red-cell changes: most patients (27/45) had moderate macrocytosis, but a few showed some microcytic hypochromic cells. Nucleated red cells were seen in 7 patients, including 2 of those classified as CEM. Granulocytes often showed defective granulation, and rarely Dohle bodies; 20 cases showed the pseudo-Pelger anomaly. Absolute monocytosis (>0 8 x 109/1) was seen in 9 cases. Occasional blast cells were present in the peripheral blood of 14 patients. Table IV shows the median and range of the survival times in months for all patients, and for patients separated into possible prognostic groups. Although the exact ages were known, the patients have been divided simply into those below and above the median age.Two patients known to be alive at 28 months and 120 months respectively have been excluded from this breakdown.
Statistical analysis
The survival times of these prognostic groups were compared by the actuarial life-table method of Kaplan and Meier, and by the log-rank test, for which the 2 patients still alive were included. Since it was difficult to distinguish deaths which were an indirect result of the disease and those from other causes, no attempt has been made to correct for intercurrent (leaths. On examination of the survival curves age, hepatomegaly, haemoglobin, platelets and blood monocytosis showed slight differences in survival, though none of these was statistically significant, pos- Table V shows the results of the Cox regression. The actual age, rather than the grouped age, was used for this analysis, and this was the most important predictor. After age, haemoglobin significantly improved the log-likelihood. A "low", as opposed to "normal", haemoglobin increased the hazard and significantly reduced the survival. Although the use of cytotoxic drugs was the next important variable, its effect was not statistically significant.
I)ISCUSSION
The incidence of smouldering leukaemia ill our clinic (abouit 10% of all cases of myeloblastic leukaemia) is similar to that reported by Dreyfus (1976) .
The definition of smouldering ("oligoblastic", subacute myeloblastic) leukaemia is based on marrow morphology and clinical presentation. The latter picture is characterized by signs of incipient Although the separationi of the variotus types of smouldering leukaemia into 3 or more subtypes on morphological grounds is frequently accepted, some have questionied its practical validity (Lichtman, 1979) . Our studies confirm this view; although it was possible to divide ouir material suibjectively into 3 major morphological groups, some cases showed overlapping features.
It seems appropriate to regard smouldering leukaemia as a continuous morphological spectrum with a number of distinctive landmarks; our 3 groups had comparable survival times, though the patients labelled as CMML seemed to fare rather better than those categorized as RAEM. We agree with Dohy et al. (1980) that refractory macrocytosis is a frequent finding in pre-leukaemic marrow dysplasia, and should be accorded the same significance as an unexplained neutropenia or thrombocytopenia.
In the blood picture, the main features determining prognosis were anaemia and thrombocytopenia at diagnosis. The total WBC did not appear to influence the outcome, but patients with higher monocyte counts did a littler better than the others. Since a high peripheral monocyte count is one of the features determining a diagnosis of CMML, this may be relevant to the marginally longer survival of this group. These patients also tended to higher haemoglobin levels, which may be significant in the light of the reported role of cells of the monocyte/macrophage series in promoting haemopoiesis (Rinehart et al., 1978) . It is also possible that a patient with an absolute monocytosis is able to compensate for chronic neutropenia.
Another interesting point concerns the degree and type of sideroblast seen in these patients. We agree with Hast & Reizenstein (1981) that a predominance of "true" ring sideroblasts is rare in preleukaemia and smouldering leukaemia, even when there is gross dyserythropoiesis. Intermediate or incomplete rings of the type described above, are, however, common (24% in ouir series). Thus the picture characteristic of idiopathic refractory sideroblastic anaemia (viz. gross mitochondrial iron overload affecting most of both early and late normoblasts (Mollin, 1965; Hall & Losowsky, 1966) ) is rare in preleukaemia. Recent work suggests that these morphological differences are reflected by distinctive ferrokinetic patterns in the two syndromes (Cazzola et al., 1982) . Apart, from anaemia, the only distinctive clinical feature apparently significant in predicting survival was hepatomegaly, which was present in 9/43 cases entered into the statistical analysis. By contrast, only 3 cases had palpable spleens at diagnosis, and so we were unable to decide whether splenomegaly alone was of prognostic significance. Cohen et al. (1979) , however, found that combined hepato-and splenomegaly in a patient with "subacute" leukaemia was a sinister feature, especially if associated with a high WBC count.
Our experience with chemotherapy in this syndrome have been disappointing as is reflected in the statistical analysis of survival. Five patients were treated during the "chronic" phase with cytotoxic drugs (usually cytosine arabinoside and thioguanine) but only 1 showed any improvement, with temporary disappearance of blast cells in the marrow; others simply became more cytopenic without clinical improvement. Experience with chemotherapy during the acute "blastic" phase was universally disappointing, and Freireich (1979) has recently, identified a previous history of smouldering leukaemia as a bad prognostic characteristic in predicting effects of chemotherapy in AML.
These studies suggest that combined analysis of morphological and clinical features, together with cytogenetic and marrow cultures, which have previously been reported on our own cases (Milner et al., 1977) and in other series, may permit a reasonably accurate prognosis at diagnosis in a new case of smouldering leukaemia.
